Fredrik Almqvist, professor in organic chemistry at Umeå University and serial entrepreneur, receives Baltic’s collaboration and entrepreneurship award. He receives the award for successfully combining entrepreneurship with excellent research in chemical production and the combat against pathogenic bacteria.
Lipigon Pharmaceuticals and AstraZeneca’s agreement, reported earlier this spring, has potential to be one of the largest deals for any life sciences SME company in Sweden. We caught Lars Öhman, chairman of Lipigon, at BIO in San Francisco to learn more on how they did it and what to expect in the future.
Umecrine Cognition has raised new funds to support clinical development of novel drug candidate GR3027 for hepatic encephalopathy – Phase I clinical trial initiated.
LunaLEC from Umeå is ranked as one of the ten most promising clean tech startups in the Nordic countries.
QureTech Bio AB, a start-up from Umeå, developing first line drugs to combat antibiotic resistance and infectious diseases, won the BIO-Europe Spring Start-up Slam, in competition with 16 other presentations from 16 other Swedish life sciences start-up companies.
On April 5th, Sweden’s ten most innovative entrepreneurs in were bestowed with awards. MYoroface, a company connected to Uminova Innovation and Biotech Umeå, were one of the companies to receive a 200 000 SEK stipend. Swedish Incubators & Science Parks (SISP) and the Åforsk foundation appointed the winners and presented the stipends to the laureates at Sveriges Innovationsriksdag in Åre.
Brain Stimulation AB is a start-up company in e-health from Umeå. The company has developed a unique treatment method that both diagnoses and rehabilitates stroke patients who suffer from one-side neglect. The company is supported by an investment from Almi Invest. The product, RehAtt™, provides brain stimulation in a fun 3D game. The game combines neuroscience, virtual reality (VR) and robotics to help more patients return to a more normal daily life.
Lipigon Pharmaceuticals today announced that it has entered into a research collaboration with AstraZeneca to conduct joint research to identify drug candidates that promote the stabilization of Lipoprotein Lipase (LPL) and may have utility in the treatment of lipid disorders and cardiovascular disease.
SpinChem AB in Umeå has recently been granted several new patents relating to the construction of its proprietary rotating bed reactors (RBR) and their use in chemical and biological processes. The applications of the RBR technology are numerous. Examples can be found in the production of biodiesel, the production of fermented beverages and the manufacturing of ingredients for pharmaceuticals and cosmetics.
Lipigon is expanding and looking for new talents.to join our team. We are looking for:
Project manager/laboratory manager with work experience from pharmaceutical industry and QC/validation.
Laboratory assistants with experience from in vitro and in vivo methodology.
BioResonator Good Eye AB, with headquarters in Umeå, develops and sells tonometer’s that significantly simplifies diagnosis of glaucoma. The company has secured two new investors to help the company to expand faster in Europe.
– Thanks to these investments, we can focus entirely on expansion and sales, says Fredrik Jonsson, CEO of BioResonator Good Eye AB.
NLS Days 2016, September 14-15, Stockholm
Seminar about MedTech and US market, September 23, Umeå
Medica Trade Fair, November 14-17, Düsseldorf, Germany
Biotech Umeå, Uminova Innovation
Box 7978, SE-907 19 Umeå